Skip Navigation

NCAC-SOT Fall Webinar: Looking Forward After 19 Years of the Endocrine Disruptor Screening Program

Friday, September 18, 2015, 9:00 AM–12:00 Noon EDT

 
In the 1990s, a variety of chemicals were suspected of disrupting the endocrine system in animals. Based on scientific evidence, Congress approved the Food Quality Protection Act and Safe Drinking Water Act (SDWA) Amendments in August 1996 requiring the US EPA to initiate the Endocrine Disruptor Screening Program (EDSP) to screen pesticides, commercial chemicals and environmental contaminants for their potential effect on the endocrine systems of humans and wildlife. EDSP is a two-tiered screening process aimed at identifying chemicals and determining their potential to disrupt the endocrine systems of mammals, birds and fish.

Tier 1: US EPA will identify chemicals that have the potential to interact with the endocrine system.

Tier 2: US EPA will determine the endocrine-related effects caused by each chemical and obtain information about effects at various doses to enable subsequent risk assessments for each chemical.
 
US EPA announced the initial list of chemicals to be screened for their potential effects on the endocrine system (or Tier 1 testing) on April 15, 2009, and in November 2010, EPA issued a finalist (“List 1”) of chemicals for screening as well as draft policies and procedures for the EDSP. The second list of chemicals (as well as related policies and procedures) for screening under the SDWA (“List 2”) was issued on June 14, 2013 (with minor revisions in May 2014); however, US EPA currently does not have authorization from the White House Office of Management and Budget (OMB) to collect these data. On June 18, 2015, US EPA announced a plan for incorporating validated high-throughput assays and a computational model into the EDSP to screen chemicals for their ability to interact with the endocrine system. This proposed new method would serve as an alternative for three of the eleven current assays in the EDSP Tier 1 screening battery (estrogen receptor binding, estrogen receptor transactivation, uterotrophic). On July 30, 2015, US EPA released its reviews of the Tier 1 screening assay results for the first 52 pesticide chemicals (active and inert ingredients) in the EDSP, representing a major milestone of achievement for the almost 20-year-old program
 
This webinar provides a great opportunity to hear about the current status of the EDSP program from stakeholders involved with the program as well different perspectives on the future directions of the program.
 
Agenda
9:00 AM–9:05 AM Welcome/Procedures and Housekeeping Remarks
9:05 AM–9:30 AM Nineteen Years of the Endocrine Disruptor Screening Program: Where We Started and Where We Are Heading
David J. Dix, PhD, Office of Science Coordination and Policy (OSCP), US EPA
9:30 AM–10:00 AM Using High-Throughput Assays and Computational Tools for Endocrine Screening
Patience Browne, PhD, Office of Science Coordination and Policy (OSCP), US EPA
10:00 AM–10:30 AM Challenges and Opportunities for Wildlife Testing
Caren Helbing, PhD, Professor Department of Biochemistry and Microbiology, University of Victoria, British Columbia, Canada
10:30 AM–11:00 AM Concepts of Endocrinology: Issues Relevant to Endocrine Disruptor Screening
Raphael Witorsch, PhD, Professor Emeritus Medical College of Virginia VCU and Consultant
11:00 AM–11:30 AM Round Table Presentations—Application of Tox21/ToxCast and the Future of Regulatory Decision Making
Industry Perspective: A Framework for Building Scientific Confidence in Tox21 and Risk21 Methods 
Rick Becker, PhD, DABT, Senior Toxicologist American Chemistry Council 
Academic Perspective: The Need for Evidence-Based Approaches 
Thomas Hartung, MD, Director Center for Alternatives to Animal Testing (CAAT), Johns Hopkins University Bloomberg School of Public Health 
Government Perspective: The Importance of Fit-for-Purpose Validation 
Warren Casey, PhD, Director at National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods (NTP/NICEATM) 
11:30 AM–12:00 Noon Round Table Discussion—Application of Tox21/ToxCast and the Future of Regulatory Decision Making
All Speakers
12:00 Noon Closing Remarks
 
 
 

New ALTEX: 3/2017
ALTEX 3/2017 cover

Support ALTWEB, Make a Gift
Online Humane Science Course

MeetingS

 
FRAME Training School in Experimental Design and Statistical Analysis
May 31-June 2, 2017
Saskatoon, Canada

Advances in Cell and Tissue Culture 2017
May 22-24, 2017
Manchester, UK

CAAT Academy
In Vitro Skin and Eye Models Hands-on Training
June 1-2 2017
Brussels, Belgium

CAAT Academy
Tools for Read-Across
June 15-16, 2017
Helsinki, Finland

ecopa SSCT Workshop 2017
June 14-16, 2017
Helsinki, Finland
Thomas Hartung will deliver a keynote address

CAAT Academy
Updates on Hepatotoxicity AOP Landscape and on the ADME Field - Season 2
June 22-23, 2017
Rennes, France

9th Euro-Global Summit on Toxicology and Applied Pharmacology
June 22-24, 2017
Paris, France
Email for Details

6th Annual Meeting of the American Society for Cellular and Computational Toxicology (ASCCT)
September 21-22
College Park, MD

SAVE THE DATE:
10th World Congress on Alternatives and Animal Use in the Life Sciences
August 20-24, 2017
Seattle, Washington

CAAT Academy
Hands-on Training in Quantitative Human Cell and Effect-based In Vitro Bioanalysis for Assessing Endocrine-disrupting Compounds (EDCs)
September 7-8. 2017
Amsterdam
 

More Meetings...